BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38609001)

  • 21. Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis.
    Ye G; Yang Q; Lei X; Zhu X; Li F; He J; Chen H; Ling R; Zhang H; Lin T; Liang Z; Liang Y; Huang H; Guo W; Deng H; Liu H; Hu Y; Yu J; Li G
    Theranostics; 2020; 10(17):7545-7560. PubMed ID: 32685004
    [No Abstract]   [Full Text] [Related]  

  • 22. JMJD2B promotes epithelial-mesenchymal transition by cooperating with β-catenin and enhances gastric cancer metastasis.
    Zhao L; Li W; Zang W; Liu Z; Xu X; Yu H; Yang Q; Jia J
    Clin Cancer Res; 2013 Dec; 19(23):6419-29. PubMed ID: 24077348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
    Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
    PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer.
    Zha L; Zhang J; Tang W; Zhang N; He M; Guo Y; Wang Z
    Dig Dis Sci; 2013 Mar; 58(3):724-33. PubMed ID: 23135750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. eIF4EBP3 was downregulated by methylation and acted as a tumor suppressor by targeting eIF4E/β-catenin in gastric cancer.
    Zhai S; Lin S; Lin Z; Xu J; Ji T; Chen K; Wu K; Liu H; Ying H; Fei W; Wang J; Fu G; Wang Y; Hu X; Cai X
    Gastric Cancer; 2020 May; 23(3):483-496. PubMed ID: 31853750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/β-catenin pathway to enhance the stemness of gastric cancer.
    Bie Q; Sun C; Gong A; Li C; Su Z; Zheng D; Ji X; Wu Y; Guo Q; Wang S; Xu H
    Sci Rep; 2016 May; 6():25447. PubMed ID: 27146881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner.
    Li H; Lan T; Xu L; Liu H; Wang J; Li J; Chen X; Huang J; Li X; Yuan K; Zeng Y; Wu H
    J Exp Clin Cancer Res; 2020 Jul; 39(1):128. PubMed ID: 32631394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PYGB Promoted Tumor Progression by Regulating Wnt/β-Catenin Pathway in Gastric Cancer.
    Xia B; Zhang K; Liu C
    Technol Cancer Res Treat; 2020; 19():1533033820926592. PubMed ID: 32462986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SIK2 represses AKT/GSK3β/β-catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases.
    Dai XM; Zhang YH; Lin XH; Huang XX; Zhang Y; Xue CR; Chen WN; Ye JX; Lin XJ; Lin X
    Mol Oncol; 2021 Jan; 15(1):228-245. PubMed ID: 33128264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LDLRAD2 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/β-catenin/EMT signaling cascade in gastric cancer.
    Wei Y; Zhang F; Zhang T; Zhang Y; Chen H; Wang F; Li Y
    Aging (Albany NY); 2019 Oct; 11(20):8951-8968. PubMed ID: 31649207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TC1(C8orf4) correlates with Wnt/beta-catenin target genes and aggressive biological behavior in gastric cancer.
    Kim B; Koo H; Yang S; Bang S; Jung Y; Kim Y; Kim J; Park J; Moon RT; Song K; Lee I
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3541-8. PubMed ID: 16740781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KDM1A Promotes Immunosuppression in Hepatocellular Carcinoma by Regulating PD-L1 through Demethylating MEF2D.
    Wang Y; Cao K
    J Immunol Res; 2021; 2021():9965099. PubMed ID: 34307695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. URG11 promotes gastric cancer growth and invasion by activation of beta-catenin signalling pathway.
    Du R; Xia L; Sun S; Lian Z; Zou X; Gao J; Xie H; Fan R; Song J; Li X; Liu J; Fan D
    J Cell Mol Med; 2010 Mar; 14(3):621-35. PubMed ID: 19413886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HOXB5 induces invasion and migration through direct transcriptional up-regulation of β-catenin in human gastric carcinoma.
    Hong CS; Jeong O; Piao Z; Guo C; Jung MR; Choi C; Park YK
    Biochem J; 2015 Dec; 472(3):393-403. PubMed ID: 26467157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of FOXC1 Promotes Tumor Metastasis by Activating the Wnt/β-Catenin Signaling Pathway in Gastric Cancer.
    Sun Y; Lin C; Ding Q; Dai Y
    Dig Dis Sci; 2022 Aug; 67(8):3742-3752. PubMed ID: 34427817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-217-regulated MEF2D-HDAC5/ND6 signaling pathway participates in the oxidative stress and inflammatory response after cerebral ischemia.
    Shi L; Tian Z; Fu Q; Li H; Zhang L; Tian L; Mi W
    Brain Res; 2020 Jul; 1739():146835. PubMed ID: 32311345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
    Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
    Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells.
    Huang J; Xiao D; Li G; Ma J; Chen P; Yuan W; Hou F; Ge J; Zhong M; Tang Y; Xia X; Chen Z
    Oncogene; 2014 May; 33(21):2737-47. PubMed ID: 23752181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The involvement of myocyte enhancer factor 2D in regulating tumor biology of cardiac myxoma.
    Huo Y; Zhao Q; Wang C; Zhao F; Du Y; Sun W
    Tumour Biol; 2016 Apr; 37(4):5405-11. PubMed ID: 26563368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDK5RAP3 acts as a tumor suppressor in gastric cancer through inhibition of β-catenin signaling.
    Wang JB; Wang ZW; Li Y; Huang CQ; Zheng CH; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Lin Y; Huang CM
    Cancer Lett; 2017 Jan; 385():188-197. PubMed ID: 27793695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.